We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
-13.18%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$480M
AUM Growth
-$62.8M
(-12%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
4.03%
Top 10 Holdings %
Top 10 Hldgs %
63.98%
Holding
64
New
7
Increased
24
Reduced
17
Closed
4
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
+$10.4M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$5.38M |
| 3 |
Denali Therapeutics
DNLI
|
+$5.07M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$4.16M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$3.88M |
Top Sells
| 1 |
Biogen
BIIB
|
+$5.47M |
| 2 |
Merck
MRK
|
+$3.85M |
| 3 |
Tesla
TSLA
|
+$2.68M |
| 4 |
Arrowhead Research
ARWR
|
+$1.98M |
| 5 |
VZLA
Vizsla Silver
VZLA
|
+$1.12M |
Sector Composition
| 1 | Healthcare | 33.85% |
| 2 | Consumer Discretionary | 24.98% |
| 3 | Technology | 24.21% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tesla
TSLA
$1.5T
| $82.5M | 17.18% |
222,000
-6,500
| -3% | -$2.68M |
|
2
Shopify
SHOP
$162B
| $48.3M | 10.05% |
407,000
-3,000
| -0.7% | -$394K |
|
3
Spotify
SPOT
$98.1B
| $32.5M | 6.76% |
67,000
-1,000
| -1% | -$502K |
|
4
Palantir
PLTR
$313B
| $29.3M | 6.09% |
200,000
| – | – |
|
5
Amazon
AMZN
$2.64T
| $26M | 5.42% |
125,000
+4,000
| +3% | +$881K |
|
|
6
Arrowhead Research
ARWR
$10.2B
| $23M | 4.79% |
366,936
-31,268
| -8% | -$1.98M |
|
|
7
Ionis Pharmaceuticals
IONS
$9.11B
| $21.8M | 4.53% |
290,024
+49,200
| +20% | +$3.88M |
|
8
Lemonade
LMND
$5.5B
| $16M | 3.33% |
255,259
+7,000
| +3% | +$484K |
|
9
NVIDIA
NVDA
$4.96T
| $14.1M | 2.94% |
81,000
| – | – |
|
10
Coinbase
COIN
$42B
| $13.8M | 2.87% |
79,000
| – | – |
|
11
Advanced Micro Devices
AMD
$907B
| $12.6M | 2.63% |
62,000
+2,000
| +3% | +$427K |
|
12
AST SpaceMobile
ASTS
$21.4B
| $12M | 2.5% |
145,000
| – | – |
|
13
Sea Limited
SE
$67.1B
| $11.4M | 2.38% |
138,000
| – | – |
|
14
Iris Energy
IREN
$13.8B
| $11M | 2.28% |
320,150
+40,150
| +14% | +$1.81M |
|
15
Axsome Therapeutics
AXSM
$11.8B
| $9.93M | 2.07% |
58,729
+1,851
| +3% | +$320K |
|
|
16
Esperion Therapeutics
ESPR
| $9.04M | 1.88% |
+3,299,441
| New | +$10.4M |
|
17
ProQR Therapeutics
PRQR
$240M
| $8.86M | 1.84% |
5,467,149
+109,387
| +2% | +$179K |
|
|
18
Biogen
BIIB
$28.7B
| $8.03M | 1.67% |
43,800
-29,680
| -40% | -$5.47M |
|
19
uniQure
QURE
$2.85B
| $7.95M | 1.66% |
486,520
+70,250
| +17% | +$1.42M |
|
20
Ultragenyx Pharmaceutical
RARE
$3.19B
| $7.64M | 1.59% |
364,802
+7,300
| +2% | +$164K |
|
21
Arcutis Biotherapeutics
ARQT
$3.33B
| $7.56M | 1.57% |
320,972
+15,000
| +5% | +$383K |
|
|
22
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.21M | 1.09% |
+92,305
| New | +$5.38M |
|
23
Vertex Pharmaceuticals
VRTX
$122B
| $5.07M | 1.06% |
11,355
+2,000
| +21% | +$933K |
|
|
24
Denali Therapeutics
DNLI
$3.67B
| $4.89M | 1.02% |
+254,857
| New | +$5.07M |
|
25
UroGen Pharma
URGN
$1.93B
| $4.28M | 0.89% |
238,122
+23,500
| +11% | +$471K |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM